M ore than 20 years ago, Lafferty and colleagues and, subsequently, Lechler and Batchelor demonstrated that the main immunogenic stimulus leading to graft rejection was provided by the migrant population of allogeneic "passenger" dendritic cells (DC) 3 present in the allografted tissue (1) (2) (3) (4) . If the graft was depleted of these cells, rejection was less strong or was absent, and graft survival was extended. However, acute rejection was restored by injection of purified donor DC at the time of transplantation. To explain the variation in susceptibility to rejection observed in normal and passenger DC-depleted allografts, the authors put forward the hypothesis that there were two pathways for sensitization of alloreactive CD4
ϩ T cells in rejection responses. Route 1, the direct pathway of sensitization, involves the direct recognition of donor MHC molecules at the surface of donor stimulatory cells and requires the presence of donor-derived passenger DC in the graft (5) . By route 2, the indirect pathway of sensitization, antigenic moieties derived from the graft are phagocytosed and processed by APC of recipient origin and presented as peptides in the binding groove of the recipient's own MHC class II molecules. According to Lafferty's hypothesis, the indirect pathway is the only route available for sensitization to donor passenger DC-depleted organs. Thus, direct cell-cell contact between alloreactive CD4
ϩ T cells and graft cells would not be required to bring about rejection of passenger DC-depleted organs.
Ample evidence indicates that indirect allorecognition occurs during allograft rejection. The indirect pathway was put forward as a hypothesis to explain the Ag specificity of the CD4 ϩ T cells responsible for the rejection of MHC class II Ag-deficient allografts (6) . Several studies in humans, rats, and mice have revealed the presence of alloreactive CD4 ϩ T cells specific to alloantigens presented as peptide fragments in association with recipient MHC molecules during allograft rejection (7) (8) (9) (10) (11) . Moreover, it has been reported that intrathymic administration of allogeneic peptides that are known to stimulate self-restricted alloreactive T cell clones can prolong the survival of subsequent allografts, suggesting that indirect presentation is critical to the rejection process (12) .
However, while it is clear that T cell clones sensitized to alloantigens through indirect recognition are present during the process of rejection, it has been hard to demonstrate whether they actually promote rejection. The main obstacle resides in the difficulty of finding situations where indirect sensitization represents the only pathway available for activation of alloreactive T cells. The most convincing approaches that have been tried to date involve either the transplantation of MHC class II molecule-deficient organs or the adoptive transfer of in vitro-derived T cells sensitized by indirect recognition of allopeptides (6, 13) . Although elegantly designed, these experiments have major weaknesses. First, they fail to unequivocally show the complete absence of direct recognition of rejected grafts by adoptively transferred T cells (13) . Moreover, they are not able to exclude the activity of unusual CD4 ϩ T cells not restricted by conventional MHC class II molecules and capable of mediating allograft rejection (14 -17) . Finally, they do not demonstrate whether, in the absence of direct recognition, T cell priming by indirect recognition of allografts is sufficient to bring about rejection. This last point is of particular relevance because memory cells contribute a substantial proportion of the cells involved in primary responses stimulated by direct recognition of donor MHC molecules (18) . In contrast, as for any nominal protein Ag, peptides derived either from allogenic MHC molecules or from polymorphic proteins and presented in the context of the recipient's own MHC molecules stimulate almost exclusively naive T cells.
To establish without ambiguity the capacity of naive CD4 ϩ T cells to reject transplanted foreign tissue through the indirect recognition pathway, we analyzed the rejection of male H-2 k skin allografts by recombinase-activating gene-2 (RAG2)-deficient mice expressing an H-Y-specific I-A b -restricted transgenic (Tg) TCR (Marilyn mice). We show here that in the strict absence of direct recognition, Marilyn CD4 ϩ T cells were not only primed by, but were also able to acutely reject, a male H-2 k skin allograft. 
Materials and Methods

Mice
Skin graft and histology
Female recipients were anesthetized and grafted on the left side of the back with tail skin (70 mm 2 ) from male donors. The grafts were secured using Vaseline gauze and a bandage. Bandages were removed on day 10, and the grafts were then visually scored daily for evidence of rejection. Grafts showing Ͼ50% necrosis were considered rejected. Skin grafts were collected from killed mice and stained with hematoxylin and eosin.
Proliferation assay and determination of cytokine secretion
Spleen cells (1 ϫ 10 5 ) isolated from TCR Tg animals at the time of skin graft rejection were mixed with titrated numbers of irradiated spleen cell stimulators in triplicates in U-bottom 96-well microplates. [ 3 H]Thymidine (1 Ci) was added for the final 16 h of a 72-h incubation. In some experiments, culture supernatants were harvested and studied in a sandwich ELISA for cytokine production. ELISA kits for mouse IFN-␥ and IL-4 were supplied by Genzyme (Cambridge, MA). For depletion of MHC class II Ag-expressing cells in the responding population, spleen cells were incubated for 30 min at room temperature in culture supernatants containing rat mAb to mouse MHC class II Ags (clone M5/114) and to mouse B220 (clone RA3-3A1; American Type Culture Collection, Manassas, VA). The cells were then submitted to complement lysis (rabbit complement; Cedarlane Laboratories, Saratoga, Canada) for 45 min at 37°C. Purity was assessed by flow cytometry with FITC-conjugated anti-I-A b -specific mAb (clone 25-9-17; BD PharMingen) specific to an epitope on the class II MHC molecule other than that recognized by M5/114 Abs. After depletion, Ͻ0.3% of cells expressing MHC class II Ag could be detected in the responding populations. (Fig. 1b) , purified Marilyn T cells did not expand for at least 7 days and retained their naive phenotype as they continued to express low levels of CD44 and high levels of CD62L. This confirms that they were unable to recognize any Ag presented by H-2 k APC in the adoptive host. In contrast, they responded well to coinjected syngeneic male spleen cells, undergoing proliferation 7 days after transfer, with up-regulation of CD44 and down-regulation of CD62L (Fig. 1b) 
Results and Discussion
Marilyn mice acutely reject H-2 k skin in the absence of cognate recognition of allograft
We next analyzed the capacity of Marilyn mice to reject H-2 kexpressing skin allografts from male donors. According to the above results, these grafts are not capable of directly stimulating Marilyn T cells. Therefore, any rejection would be the result of T cell activation by recipient I-A b APC that had processed and presented H-Y Ags shed by the graft. The survival of skin from H-2 k male donors on Marilyn recipients is compared in Fig. 2 with that of skin from H-2 k female donors. Male H-2 k skin grafts were rejected within 12 days, whereas female H-2 k skin grafts enjoyed indefinite survival and kept a syngeneic aspect for up to 30 days after transplantation, when the experiment was terminated. Because our model involved the transplantation of normal skin onto immunodeficient recipients, one cannot exclude the possibility that donor-derived T lymphocytes transferred by the graft could participate in a graft-vs-host reaction that would initiate the inflammatory processes leading to allograft rejection (23) . To rule out this possibility, we also transplanted skin allografts isolated from T cell-deficient RAG2 Ϫ/Ϫ male H-2 k donors onto the Marilyn recipients. As shown in Fig. 2 , the absence of T cells in grafted skin did not modify the profile of rejection. All RAG2 Ϫ/Ϫ H-2 k -expressing male allografts were acutely rejected, while female grafts enjoyed long term survival. The histology of rejected skin allografts revealed the presence of dense cellular infiltrates in both the derma and epiderma, mainly composed of macrophage-like cells and lymphocytes, although a few eosinophils were also noticed (Fig. 3) . By contrast, long-term-surviving female grafts did not show signs of histological lesions nor did they contain infiltrating lymphoid cells (Fig. 3) . Taken together, these observations show unequivocally that primary immunization of alloreactive CD4 ϩ T cells by indirect recognition of graft Ags is sufficient by itself to promote allograft rejection, therefore demonstrating indirect allorecognition of grafted tissue as an efficient pathway for the rejection process.
We started these experiments in the hope of comparing the quantitative strengths of effector mechanisms of graft rejection mediated by direct vs indirect alloantigen presentation and to analyze the immunohistopathology characterizing each system. However, we did not notice any difference in the kinetics of the rejection responses for H-2 k male skin (indirect) and H-2 b male skin (direct and indirect; data not shown). Moreover, careful analysis of the histopathology associated with the two types of rejection did not reveal differences (data not shown). Thus, it would appear that the effector mechanisms used by T cells sensitized by direct or indirect allorecognition in our Tg model do not promote distinct pathology in rejected skin.
The striking features of the rejection of an allograft are the specific destruction of graft elements and the absence of significant damages to host tissues that are close to or in direct contact with the graft. These have led to the widely accepted view that immunologically specific mechanisms of tissue destruction, i.e., CTL activity, Abs, etc., are responsible for the rejection of allografts. Early works on the rejection of mosaic skin from allophenic mice grafted onto one of the parent strains provide direct evidence for the Ag specificity of the effector mechanism of allograft rejection (24 -26) . In these grafts only cells that express the target alloantigen are destroyed, whereas cells that are syngeneic to the recipient survive indefinitely. The absence of substantial damage to bystander syngeneic cells in the graft has fostered the idea that allograft rejection is the result of specific killing of graft cells by humoral or cell-mediated cytotoxicity. However, several observations suggest that nonspecific mechanisms of tissue destruction also participate in graft rejection. First is the observation that the syngeneic elements of allophenic grafts endure some degree of damage during rejection on parental recipients, but unlike the allogeneic compartment of the grafts, they are not fully destroyed, and most of them survive indefinitely (25) . A second piece of evidence is the rejection of chimeric skin in which graft parenchyma cells are syngeneic to the recipient and only skin passenger leukocytes, i.e., Langerhans cells, express allogeneic MHC molecules (27) . In this setting acute rejection would be the direct result of immunologically nonspecific destruction of graft cells. Our study demonstrates the capacity of immunologically nonspecific effector mechanisms to bring about graft rejection. Because of their genetic deficiency, RAG2 Ϫ/Ϫ TCR Tg recipients do not contain mature B or T cells other than those expressing the TCR transgene and thus cannot develop Ag-specific effector mechanisms of rejection against male H-2 k allografts.
Rejection of H-2 k skin allograft does not polarize Marilyn CD4 ϩ T cells toward Th1 or Th2 phenotype
We next analyzed the reactivity of Tg Marilyn T cells from mice that had rejected H-2 k male skin allografts. For MLR, spleen cells were stimulated with irradiated H-2 k or H-2 b male or female stimulators. As depicted in Fig. 4 , unpurified Marilyn spleen cells proliferated in response to both H-2 k and H-2 b male cells, while they did not respond to female stimulators. The cells also specifically secreted both IFN-␥ and IL-4 (Fig. 4) . However, reactivity toward b female (n ϭ 4) (Ⅺ) or male (n ϭ 6; Ⅺ) C57BL/6 mice, H-2 k female (n ϭ 9; E) or male (n ϭ 10; F) C3H mice, or female (n ϭ 6; ‚) or male (n ϭ 5; OE) RAG2 Ϫ/Ϫ H-2 k mice were transplanted onto Marilyn TCR Tg recipients. The results represent two pooled independent experiments. H-2 k male cells was completely abrogated by depletion of MHC class II Ag-expressing cells from the responding population (Fig.  4) . This observation confirms that Marilyn's reactivity toward H-2 k male cells is indeed the result of indirect recognition of H-Y presented by I-A b and requires H-2 b APC in the assay. The fact that IFN-␥ and IL-4 were secreted in vitro by Marilyn T cells after stimulation with male cells suggests that both Th1-and Th2-dependent effector pathways of rejection operate in this system. Among pathways considered as being Th1 mediated, classical CTL can be ruled out, because it requires cognate recognition between effector CD4
ϩ T cells and target graft cells. However, because keratinocytes, like hepatocytes, are sensitive to CD95-mediated apoptosis and express CD95L following exposure to inflammatory cytokines (28), one should not discard a possible role for Fas-mediated apoptosis of keratinocytes in the rejection process (29) . The presence of numerous macrophage-like cells in allograft infiltrates suggests a delayed-type hypersensitivity-like reaction to be the main pathway of rejection. In contrast, the presence of eosinophilic infiltrates in rejected allografts supports the idea that a Th2-dependent pathway of rejection involving IL-5 and eosinophils may be operating in our model (30) . Because we used RAG2 Ϫ/Ϫ recipients, a role for B cell Abs and classical CTL in the rejection process can be ruled out.
Concluding remarks
It is often assumed that, during rejection, the peptides recognized by indirect pathway CD4 ϩ T cells come mainly from the processing and presentation by recipient APCs of polymorphic moieties derived from donor MHC molecules (31) . Our study confirms early findings by Wettstein et al. (32) that rejection by T cells also involve the indirect recognition of peptides from minor transplantation Ags. Thus, minor histocompatibility Ags, such as H-Y Ag and polymorphic molecules, must also be considered as a source of allopeptides for indirect allorecognition in the design of peptidebased immune intervention that would interfere with the rejection process.
The important finding of our study is that the indirect pathway of alloantigen recognition can alone mediate the acute rejection of fully histoincompatible allografts. Because we are using TCR Tg recipients, one could question the relevance of such an observation. Indeed, it could be argued that this situation results from the stimulation of an abnormally high number of indirect pathway T cells and that this would not occur in non-Tg recipients. In animal models, direct pathway T cells have been estimated to represent Ͼ90% of the T cell repertoire participating in the process of acute rejection, whereas indirect pathway T cells would include only 1-10% (11). However, one should not forget that the ratio of direct-over-indirect pathway T cells might be profoundly perturbed in clinical situations where sensitization to donor alloantigens has taken place before transplantation (33, 34) . Indeed, previous exposure to antigenic peptides has been reported to induce dramatic expansion of Ag-specific oligoclonal T cell populations (35) (36) (37) . Thus, in some donor/recipient combinations, indirect pathway T cells may dominate the alloresponse and mediate allograft rejection. 
